Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2022-04-12 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-04-12 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the closing of a non-brokered private placement by Izotropic Corporation. It details the issuance of unsecured promissory notes and warrants, the terms of the notes, use of proceeds, and legal disclaimers about securities registration. There is no financial report, earnings data, or management discussion. The content focuses on financing activity and capital raising. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is 5841 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Hence, the classification is CAP with high confidence.
2022-04-04 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-03-31 English
Interim MD&A - English.pdf
Regulatory Filings
2022-03-31 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-03-31 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing a non-brokered private placement by Izotropic Corporation. It details the terms of the offering, including the issuance of unsecured promissory notes and detachable share purchase warrants, the intended use of proceeds, and regulatory disclaimers. There is no financial report, earnings data, or management discussion of financial results. The content focuses on fundraising activity and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is over 6000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2022-03-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.